• Gut Protein Found to Protect Against Infection, Intestinal Breakdown
    A protein that binds to bile in the small intestine may hold the key to preventing infection and intestinal breakdown in people with conditions such as obstructive jaundice or irritable bowel syndrome, researchers at UT Southwestern Medical Center have discovered. “What ...More
    February 6, 2006 Posted in News
  • Most Common Hepatitis C Virus Type Grown in Lab for First Time
    Researchers at the University of Texas Medical Branch at Galveston (UTMB) have successfully grown the most common and damaging form of the hepatitis C virus in human liver cell cultures. This achievement — the first laboratory cultivation of a “genotype 1” hepatitis C virus ...More
    February 6, 2006 Posted in News
  • FDA Approves New Laboratory Test to Detect Human Infections With Avian Influenza A/H5 Viruses
    HHS' Food and Drug Administration (FDA) today announced the approval of a new laboratory test to diagnose H5 strains of influenza in patients suspected to be infected with the virus. The test was developed by another HHS agency, the Centers for Disease Control and ...More
    February 6, 2006 Posted in News
  • FDA Orders Biomedical Tissue Services, Ltd., to Cease Manufacturing
    Under its comprehensive framework for ensuring the safety of human tissue products, the U.S. Food and Drug Administration (FDA) today ordered Biomedical Tissue Services, Ltd. (BTS), of Fort Lee, N.J., a human tissue-recovery firm, and its CEO and executive director of ...More
    February 6, 2006 Posted in News
  • sanofi pasteur Delivers More H5N1 Vaccine for U.S. Pandemic Initiatives
    SWIFTWATER, Pa. and LYON, France -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group, has delivered more H5N1 vaccine to the U.S. government including investigational doses formulated with an adjuvant. Sanofi pasteur has shipped to the U.S. National ...More
    February 6, 2006 Posted in News
  • HHS and Institut Pasteur Partner on Pandemic Influenza Preparedness
    PARIS -- The U.S. Department of Health and Human Services (HHS) and Institut Pasteur (IP) today agreed to carry out joint activities, beginning in southeast Asia, to strengthen global capacity to detect influenza viruses that could have the potential to trigger a human ...More
    February 6, 2006 Posted in News
  • The Long Research Road to a New Vaccine
    The Food and Drug Administration (FDA) today announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year. The vaccine, developed by Merck ...More
    February 6, 2006 Posted in News
  • Rapid Diagnosis of Urinary Tract Infections with Novel Biosensor Technology
    For the millions of people who suffer from urinary tract infections each year and the doctors who treat them, a promising new biosensor technology has been developed that may replace antiquated testing methods and save precious health care dollars. In a recent clinical ...More
    February 3, 2006 Posted in News
  • Evidence Supports Call Not to Use Certain Type of Anti-viral Drugs for Flu
    Recent, additional data show that the prevalence of adamantane-resistant influenza A viruses is high across the United States, according to a new study published online today by JAMA because of its public health importance. The study will be published in the Feb. 22 print ...More
    February 3, 2006 Posted in News
  • Ironing Out New Details of Tuberculosis Infection
    Scientists in India, led by a Howard Hughes Medical Institute (HHMI) international research scholar, have identified five key genes that enable Mycobacterium tuberculosis to acquire the iron it needs to sustain growth and promote infection. “Targeting genes within this ...More
    February 3, 2006 Posted in News